Accessibility Menu
 
Abcam Plc logo

Abcam Plc

(NASDAQ) ABCM

Current PriceN/A
Market CapN/A
Since IPO (2020)+21%
5 YearN/A
1 Year+49%
1 Month+3%

Abcam Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$780.21M

Net Income (TTM)

$15.27M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ABCM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abcam Plc

Industry

Biotechnology

Employees

1,800

CEO

Alan Thomas Hirzel, MBA

Headquarters

Cambridge, CB2 0AX, GB

ABCM Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

2%

Net Income Margin

1%

Return on Equity

1%

Return on Capital

1%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$270.50M

Operating Income

$10.20M

EBITDA

$42.70M

Operating Cash Flow

$28.70M

Capital Expenditure

$41.30M

Free Cash Flow

$12.60M

Cash & ST Invst.

$89.00M

Total Debt

$223.90M

Abcam Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$203.20M

+21.2%

Gross Profit

$154.90M

+27.3%

Gross Margin

76.23%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

1,760

N/A

Net Income

$16.80M

+101.2%

EBITDA

$49.20M

+105.9%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$138.00M

-226.1%

Accounts Receivable

$108.60M

+103.8%

Inventory

$66.30M

+44.4%

Long Term Debt

$89.50M

-12.6%

Short Term Debt

$127.50M

+1474.1%

Return on Assets

0.45%

N/A

Return on Invested Capital

0.80%

N/A

Free Cash Flow

$17.60M

+1576.2%

Operating Cash Flow

$27.30M

-32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ISEEIVERIC bio, Inc.
$39.95+0.38%
ALPNAlpine Immune Sciences, Inc.
$64.97+0.02%
RETAReata Pharmaceuticals, Inc.
$172.36+0.02%
OPTOpthea Limited
$3.41+1.49%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ABCM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.